Label: TYVASO DPI- treprostinil inhalant
TYVASO DPI- treprostinil kit

  • NDC Code(s): 66302-600-02, 66302-610-02, 66302-616-03, 66302-620-03, view more
  • Packager: United Therapeutics Corporation
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated December 13, 2024

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use TYVASO DPI safely and effectively. See full prescribing information for TYVASO DPI. TYVASO DPI® (treprostinil) inhalation powder ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    1.1 Pulmonary Arterial Hypertension - Tyvaso DPI is indicated for the treatment of pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies with Tyvaso establishing ...
  • 2 DOSAGE AND ADMINISTRATION
    2.1 Administration - Use Tyvaso DPI only with the Tyvaso DPI Inhaler. Tyvaso DPI is administered using a single inhalation per cartridge. Administer Tyvaso DPI in 4 separate, equally spaced ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Inhalation powder: Single-dose plastic cartridges containing 16 mcg, 32 mcg, 48 mcg, 64 mcg, or 80 mcg of treprostinil as a dry powder formulation.
  • 4 CONTRAINDICATIONS
    None.
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Risk of Symptomatic Hypotension - Treprostinil is a pulmonary and systemic vasodilator. In patients with low systemic arterial pressure, treatment with Tyvaso DPI may produce symptomatic ...
  • 6 ADVERSE REACTIONS
    The following potential adverse reactions are described in Warnings and Precautions (5): - Decrease in systemic blood pressure [see Warnings and Precautions (5.1)]. - Bleeding [see Warnings and ...
  • 7 DRUG INTERACTIONS
    7.1 Bosentan - In a human pharmacokinetic study conducted with bosentan (250 mg/day) and an oral formulation of treprostinil (treprostinil diolamine), no pharmacokinetic interactions between ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Risk Summary - Limited case reports of treprostinil use in pregnant women are insufficient to inform a drug-associated risk of adverse developmental outcomes. However, there ...
  • 10 OVERDOSAGE
    In general, symptoms of overdose with inhaled treprostinil include flushing, headache, hypotension, nausea, vomiting, and diarrhea. Provide general supportive care until the symptoms of overdose ...
  • 11 DESCRIPTION
    11.1 Tyvaso DPI Cartridges - Tyvaso DPI consists of single-dose plastic cartridges filled with a white powder containing 1% of treprostinil, a prostacyclin mimetic, which is intended for ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Treprostinil is a prostacyclin analogue. The major pharmacologic actions of treprostinil are direct vasodilation of pulmonary and systemic arterial vascular beds and ...
  • 13 NONCLINICAL TOXICOLOGY
    13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility - A 2-year rat carcinogenicity study was performed with treprostinil inhalation at target doses of 5.26, 10.6, and 34.1 mcg/kg/day. There ...
  • 14 CLINICAL STUDIES
    14.1 Pulmonary Arterial Hypertension (WHO Group 1) (TRIUMPH I) TRIUMPH I, was a 12-week, randomized, double-blind, placebo-controlled, multicenter study of patients with PAH (NCT00147199). The ...
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    Tyvaso DPI (treprostinil) inhalation powder is available as 16 mcg, 32 mcg, 48 mcg, 64 mcg, or 80 mcg of treprostinil in single-dose plastic cartridges with approximate fill weights of 1.6 mg, 3.2 ...
  • 17 PATIENT COUNSELING INFORMATION
    Advise the patient to read the FDA-approved patient labeling (Instructions for Use). Train patients in the administration process for Tyvaso DPI, including dosing, Tyvaso DPI Inhaler setup ...
  • SPL UNCLASSIFIED SECTION
    ©Copyright 2024 United Therapeutics Corp. All rights reserved. Tyvaso DPI® and Tyvaso® are registered trademarks of United Therapeutics Corporation. Tyvaso DPI manufactured by: MannKind ...
  • INSTRUCTIONS FOR USE
    Instructions - for Use - TYVASO [ tī-vā'-sō ] DPI® (treprostinil) Inhalation Powder - For oral inhalation only - Table of Contents - page(s) Read Before Starting1 - Important ...
  • PRINCIPAL DISPLAY PANEL - 16 mcg Maintenance Kit
    NDC 66302-616-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 16 mcg per cartridge - + 5 - Inhalers - This MAINTENANCE KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 16 mcg Institutional Kit
    NDC 66302-716-04 - Rx ONLY - Institutional Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 16 cartridges, each containing - 16 mcg per cartridge - + 2 - Inhalers - This INSTITUTIONAL KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 32 mcg Maintenance Kit
    NDC 66302-632-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 32 mcg per cartridge - + 5 - Inhalers - This MAINTENANCE KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 32 mcg Institutional Kit
    NDC 66302-732-04 - Rx ONLY - Institutional Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 16 cartridges, each containing - 32 mcg per cartridge - + 2 - Inhalers - This INSTITUTIONAL KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 48 mcg Maintenance Kit
    NDC 66302-648-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 48 mcg per cartridge - + 5 - Inhalers - This MAINTENANCE KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 48 mcg Institutional Kit
    NDC 66302-748-04 - Rx ONLY - Institutional Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 16 cartridges, each containing - 48 mcg per cartridge - + 2 - Inhalers - This INSTITUTIONAL KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 64 mcg Maintenance Kit
    NDC 66302-664-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 64 mcg per cartridge - + 5 - Inhalers - This MAINTENANCE KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 64 mcg Institutional Kit
    NDC 66302-764-04 - Rx ONLY - Institutional Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 16 cartridges, each containing - 64 mcg per cartridge - + 2 - Inhalers - This INSTITUTIONAL KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 80 mcg Maintenance Kit
    NDC 66302-680-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 80 mcg per cartridge - + 5 - Inhalers - This MAINTENANCE KIT is NOT intended - for initial ...
  • PRINCIPAL DISPLAY PANEL - 80 mcg Institutional Kit
    NDC 66302-780-04 - Rx ONLY - Institutional Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 16 cartridges, each containing - 80 mcg per cartridge - + 2 - Inhalers - This INSTITUTIONAL KIT is NOT intended - for ...
  • PRINCIPAL DISPLAY PANEL - 16 mcg 32 mcg Titration Kit
    NDC 66302-600-02 - Rx ONLY - Titration Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 16 mcg per cartridge - 84 cartridges, each containing - 32 mcg per cartridge - + 5 ...
  • PRINCIPAL DISPLAY PANEL - 32 mcg 48 mcg Maintenance Kit
    NDC 66302-620-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 32 mcg per cartridge - 112 cartridges, each containing - 48 mcg per cartridge - + 5 ...
  • PRINCIPAL DISPLAY PANEL - 32 mcg 64 mcg Maintenance Kit
    NDC 66302-630-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 32 mcg per cartridge - 112 cartridges, each containing - 64 mcg per cartridge - + 5 ...
  • PRINCIPAL DISPLAY PANEL - 48 mcg 64 mcg Maintenance Kit
    NDC 66302-640-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 48 mcg per cartridge - 112 cartridges, each containing - 64 mcg per cartridge - ...
  • PRINCIPAL DISPLAY PANEL - 32 mcg 48 mcg Institutional Kit
    NDC 66302-720-04 - Rx ONLY - Institutional Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 16 cartridges, each containing - 32 mcg per cartridge - 16 cartridges, each containing - 48 mcg per cartridge - + 2 ...
  • PRINCIPAL DISPLAY PANEL - 16 mcg 32 mcg 48 mcg Titration Kit
    NDC 66302-610-02 - Rx ONLY - Titration Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 16 mcg per cartridge - 112 cartridges, each containing - 32 mcg per cartridge - 28 ...
  • PRINCIPAL DISPLAY PANEL - 16 mcg 48 mcg 64 mcg Maintenance Kit
    NDC 66302-650-03 - Rx ONLY - Maintenance Kit - FOR ORAL INHALATION ONLY - KIT CONTAINS: 112 cartridges, each containing - 16 mcg per cartridge - 112 cartridges, each containing - 48 mcg per cartridge - 112 ...
  • INGREDIENTS AND APPEARANCE
    Product Information